121 related articles for article (PubMed ID: 2636823)
1. Effect of trimetazidine on early and delayed doxorubicin myocardial toxicity.
Perletti G; Monti E; Paracchini L; Piccinini F
Arch Int Pharmacodyn Ther; 1989; 302():280-9. PubMed ID: 2636823
[TBL] [Abstract][Full Text] [Related]
2. [The prevention of the myocardial toxicity of doxorubicin with superoxide dismutase].
Villani F; Galimberti M; Favalli L; Rozza A; Lanza E; Poggi P
G Ital Cardiol; 1991 Jun; 21(6):633-41. PubMed ID: 1743445
[TBL] [Abstract][Full Text] [Related]
3. Continuous electrocardiogram reveals differences in the short-term cardiotoxic response of Wistar-Kyoto and spontaneously hypertensive rats to doxorubicin.
Hazari MS; Haykal-Coates N; Winsett DW; Costa DL; Farraj AK
Toxicol Sci; 2009 Jul; 110(1):224-34. PubMed ID: 19407338
[TBL] [Abstract][Full Text] [Related]
4. The modulatory effect of lithium on doxorubicin-induced cardiotoxicity in rat.
Rahimi Balaei M; Momeny M; Babaeikelishomi R; Ejtemaei Mehr S; Tavangar SM; Dehpour AR
Eur J Pharmacol; 2010 Sep; 641(2-3):193-8. PubMed ID: 20534381
[TBL] [Abstract][Full Text] [Related]
5. Effect of ICRF-187 pretreatment against doxorubicin-induced delayed cardiotoxicity in the rat.
Villani F; Galimberti M; Monti E; Cova D; Lanza E; Rozza-Dionigi A; Favalli L; Poggi P
Toxicol Appl Pharmacol; 1990 Feb; 102(2):292-9. PubMed ID: 2105541
[TBL] [Abstract][Full Text] [Related]
6. Electrocardiographic and biochemical evidence for the cardioprotective effect of vitamin E in doxorubicin-induced acute cardiotoxicity in rats.
Puri A; Maulik SK; Ray R; Bhatnagar V
Eur J Pediatr Surg; 2005 Dec; 15(6):387-91. PubMed ID: 16418954
[TBL] [Abstract][Full Text] [Related]
7. Comparison of doxorubicin- and MEN 10755-induced long-term progressive cardiotoxicity in the rat.
Cirillo R; Sacco G; Venturella S; Brightwell J; Giachetti A; Manzini S
J Cardiovasc Pharmacol; 2000 Jan; 35(1):100-8. PubMed ID: 10630739
[TBL] [Abstract][Full Text] [Related]
8. The influence of amrinone on cardiac toxicity induced by adriamycin in rats.
Bernardini C; Del Tacca M; Danesi R; Della Torre P
Arch Int Pharmacodyn Ther; 1986 Oct; 283(2):243-53. PubMed ID: 3789887
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin-induced late cardiotoxicity: delayed impairment of Ca2+-handling mechanisms in the sarcoplasmic reticulum in the rat.
Chugun A; Temma K; Oyamada T; Suzuki N; Kamiya Y; Hara Y; Sasaki T; Kondo H; Akera T
Can J Physiol Pharmacol; 2000 Apr; 78(4):329-38. PubMed ID: 10772060
[TBL] [Abstract][Full Text] [Related]
10. Comparative long-term study of the toxicities of free and liposome-associated doxorubicin in mice after intravenous administration.
Gabizon A; Meshorer A; Barenholz Y
J Natl Cancer Inst; 1986 Aug; 77(2):459-69. PubMed ID: 3461207
[TBL] [Abstract][Full Text] [Related]
11. [The effect of superoxide dismutase and catalase on the delayed toxicity of doxorubicin].
Villani F; Galimberti M; Poggi P; Rozza A; Lanza E; Favalli L; Scavini C
Cardiologia; 1992 Oct; 37(10):709-11. PubMed ID: 1296877
[TBL] [Abstract][Full Text] [Related]
12. Effects of ibuprofen on doxorubicin toxicity.
Inchiosa MA; Smith CM
Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):63-78. PubMed ID: 2139234
[TBL] [Abstract][Full Text] [Related]
13. Procyanidins produce significant attenuation of doxorubicin-induced cardiotoxicity via suppression of oxidative stress.
Li W; Xu B; Xu J; Wu XL
Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):192-7. PubMed ID: 19143757
[TBL] [Abstract][Full Text] [Related]
14. Preclinical evaluation of the cardiac toxicity of HMR-1826, a novel prodrug of doxorubicin.
Platel D; Bonoron-Adèle S; Dix RK; Robert J
Br J Cancer; 1999 Sep; 81(1):24-7. PubMed ID: 10487608
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular effects of doxorubicin-induced toxicity in the intact Lou/M Wsl rat and in isolated heart preparations.
de Wildt DJ; de Jong Y; Hillen FC; Steerenberg PA; van Hoesel QG
J Pharmacol Exp Ther; 1985 Oct; 235(1):234-40. PubMed ID: 4045723
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cardiotoxic, nephrotoxic and neurotoxic effects of doxorubicin by ICRF-159.
Tian Hu S; Brändle E; Zbinden G
Pharmacology; 1983; 26(4):210-20. PubMed ID: 6844396
[TBL] [Abstract][Full Text] [Related]
17. Isolated mouse atrium as a model to study anthracycline cardiotoxicity: the role of the beta-adrenoceptor system and reactive oxygen species.
de Jong J; Schoofs PR; Onderwater RC; van der Vijgh WJ; Pinedo HM; Bast A
Res Commun Chem Pathol Pharmacol; 1990 Jun; 68(3):275-89. PubMed ID: 2166963
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotective properties of O-(beta-hydroxyethyl)-rutosides in doxorubicin-pretreated BALB/c mice.
van Acker SA; Voest EE; Beems DB; Madhuizen HT; de Jong J; Bast A; van der Vijgh WJ
Cancer Res; 1993 Oct; 53(19):4603-7. PubMed ID: 8402634
[TBL] [Abstract][Full Text] [Related]
19. Free radical-dependent DNA lesions are involved in the delayed cardiotoxicity induced by adriamycin in the rat.
Monti E; Prosperi E; Supino R; Bottiroli G
Anticancer Res; 1995; 15(1):193-7. PubMed ID: 7733633
[TBL] [Abstract][Full Text] [Related]
20. Role of (+-)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF-187) in modulating free radical scavenging enzymes in doxorubicin-induced cardiomyopathy.
Alderton P; Gross J; Green MD
Cancer Res; 1990 Aug; 50(16):5136-42. PubMed ID: 2116226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
